BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31934818)

  • 1. Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading.
    Frey C; Koliopoulou AG; Montenont E; Tolley ND; Javan H; McKellar SH; Drakos SG; Selzman CH; Rondina MT
    Platelets; 2020 Oct; 31(7):952-959. PubMed ID: 31934818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
    Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
    Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Inflammatory Response Syndrome After Contentious-Flow Left Ventricular Assist Device Implantation and Change in Platelet Mitochondrial Membrane Potential.
    Mondal NK; Sorensen EN; Feller ED; Pham SM; Griffith BP; Wu ZJ
    J Card Fail; 2015 Jul; 21(7):564-71. PubMed ID: 25921521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices.
    Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
    Thromb Res; 2017 Oct; 158():140-148. PubMed ID: 28915447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support.
    Drakos SG; Badolia R; Makaju A; Kyriakopoulos CP; Wever-Pinzon O; Tracy CM; Bakhtina A; Bia R; Parnell T; Taleb I; Ramadurai DKA; Navankasattusas S; Dranow E; Hanff TC; Tseliou E; Shankar TS; Visker J; Hamouche R; Stauder EL; Caine WT; Alharethi R; Selzman CH; Franklin S
    Circulation; 2023 Jan; 147(5):409-424. PubMed ID: 36448446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices.
    Mondal NK; Li T; Chen Z; Chen HH; Sorensen EN; Pham SM; Sobieski MA; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
    Mol Cell Biochem; 2017 Sep; 433(1-2):125-137. PubMed ID: 28343311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device.
    Tseng CCS; Huibers MMH; Gaykema LH; Siera-de Koning E; Ramjankhan FZ; Maisel AS; de Jonge N
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29325227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIbα and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support.
    Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
    ASAIO J; 2018; 64(4):462-471. PubMed ID: 28953486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spleen size improvement in advanced heart failure patients using a left ventricular assist device.
    Hiraiwa H; Okumura T; Sawamura A; Kondo T; Kazama S; Kimura Y; Shibata N; Arao Y; Oishi H; Kato H; Kuwayama T; Yamaguchi S; Furusawa K; Morimoto R; Murohara T
    Artif Organs; 2020 Jul; 44(7):700-708. PubMed ID: 32017166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.
    Catino AB; Ferrin P; Wever-Pinzon J; Horne BD; Wever-Pinzon O; Kfoury AG; McCreath L; Diakos NA; McKellar S; Koliopoulou A; Bonios MJ; Al-Sarie M; Taleb I; Dranow E; Fang JC; Drakos SG
    Eur J Heart Fail; 2018 Jan; 20(1):164-174. PubMed ID: 29094485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure etiology and risk of right heart failure in adult left ventricular assist device support: the European Registry for Patients with Mechanical Circulatory Support (EUROMACS).
    Løgstrup BB; Nemec P; Schoenrath F; Gummert J; Pya Y; Potapov E; Netuka I; Ramjankhan F; Parner ET; De By T; Eiskjaer H
    Scand Cardiovasc J; 2020 Oct; 54(5):306-314. PubMed ID: 32552049
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences in Plasma Redox Status and Leukocyte Activation.
    Mondal NK; Sorensen EN; Pham SM; Koenig SC; Griffith BP; Slaughter MS; Wu ZJ
    Artif Organs; 2016 May; 40(5):434-43. PubMed ID: 26416627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device.
    Francis GS; Anwar F; Bank AJ; Kubo SH; Jessurun J
    J Card Fail; 1999 Dec; 5(4):308-15. PubMed ID: 10634672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal comparison of health-related quality of life in rural and urban recipients of left ventricular assist devices.
    Alonso WW; Faulkner KM; Pozehl BJ; Hupcey JE; Kitko LA; Lee CS
    Res Nurs Health; 2020 Aug; 43(4):396-406. PubMed ID: 32627852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
    Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
    J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
    J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression and genomic patient stratification following left ventricular assist device support.
    Blaxall BC; Tschannen-Moran BM; Milano CA; Koch WJ
    J Am Coll Cardiol; 2003 Apr; 41(7):1096-106. PubMed ID: 12679207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.